Interesting post from AOL follows - no idea if there's any truth in it, but it sounds good..........Graham
---------------------->
First of all, know that I do not know the facts about which I am about to ask a question. I have followed IPIC daily for 3 years, so I am well aware of the recent developments. Yesterday, my broker (who is following IPIC now only after my insistence) called me to ask if I had heard anything about either bucindolol or citicholine coming out in October. He specifically asked if I knew
anything about a scoring system that the FDA uses (and which apparently anyone in the field would therefore be interested in knowing) to determine the likelihood of fast approval. He said there is a system of "points", generally 40 possible points out of which apparently citicholine (or possibly bucindolol?) is expected to score 39. He said his source is usually a very good source who knows alot about this. I have never heard of it and with
the way the trials with citicholine went, I would be surprised that they would score a 39, unless safety profile weighs very heavily in the computation. Nontheless, I am hopeful that he is right. Please know that he is not trying to sell me any IPIC, and he did not buy the shares I own for me. He was really trying to confirm a rumor that he was hearing. I guess that is what I am doing in this note. PLEASE UNDERSTAND THAT I DO NOT HAVE ANY
FIRST HAND KNOWLEDGE THAT THIS IS EVEN REMOTELY TRUE. I am simply asking if anyone else has heard anything similar. I am loaded up long on IPIC and have been for 3 years, but like everyone else, getting anxious and sometimes frustrated trying to understand the price movement. If this does turn out to be true, with a drug approved as early as Oct or even Nov, I think we see the price right away into the upper 20s or even low 30s. Please post
if you have any information at all about citicholine's release or the so-called "scoring system" described above. Good luck to all. |
